U.S. Physical Therapy's Rally Raises Valuation Concerns: Analysts Flag Risks, Suggest Alternative
Despite a 19% surge in six months, analysts question U.S. Physical Therapy's (USPH) long-term prospects, citing scale limitations, declining cash flow margins, and falling returns on capital. With shares trading at a premium, the focus shifts to more resilient opportunities.